Clinical Trials Insight: 700015961

Trial Profile

Clinical Trials Insight: 700015961

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Dec 2007

At a glance

  • Drugs AVE 1642 (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 12 Dec 2007 Positive results were presented at the 49th annual meeting of the American Society of Hematology (ASH).
    • 09 Dec 2007 Status changed from inititated to in progress.
    • 27 Nov 2007 Results to be presented at ASH 2007.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top